title: [Pharmacokinetics of cardiovascular drugs in the elderly].
abstract: Adverse drug effects are more frequent in elderly patients, especially with drugs that have small safety margins. This is the case of many cardiovascular drugs. Patients who are frail, owing to their age and their psychomotor, nutritional and social stratus, are particularly at risk. Two pharmacokinetic factors appear to be of major concern, namely the age-related decrease renal function and changes in drug metabolism and distribution. Renal function is probably the single factor most responsible for altered drug levels in the elderly. The normal age-related decrease in creatinine clearance can lead to the accumulation of drugs that are normally excreted by the kidneys without being inactivated Dose adjustment of such drugs is usually based on the Cockcroft-Gault formula of creatinine clearance. Changes in hepatic metabolism and drug distribution are less commonly taken into account. The avoidance of drug toxicity requires familiarity with the medications prescribed and particular vigilance for signs of adverse effects.
authors.affiliation: Cardiologie, Hôpital de Hautepierre, Avenue Molière, 67200 Strasbourg. pharmacovigilance@chru-strasbourg.fr
authors.forename: Jean-Louis
authors.initials: JL
authors.lastname: Imbs
authors.forename: Marie
authors.initials: M
authors.lastname: Welsch
authors.forename: Silviana
authors.initials: S
authors.lastname: Lates
mesh_terms: D000367:Age Factors; D000368:Aged; D000925:Anticoagulants / Q000493:pharmacokinetics; D002317:Cardiovascular Agents / Q000378:metabolism / Q000493:pharmacokinetics*; D015331:Cohort Studies; D003404:Creatinine / Q000652:urine; D004077:Digoxin / Q000493:pharmacokinetics; D004232:Diuretics / Q000493:pharmacokinetics; D011307:Drug Prescriptions; D016330:Frail Elderly; D006493:Heparin / Q000493:pharmacokinetics; D006801:Humans; D007408:Intestinal Absorption; D007668:Kidney / Q000187:drug effects / Q000378:metabolism; D008099:Liver / Q000187:drug effects / Q000378:metabolism; D008875:Middle Aged; D011446:Prospective Studies; D012307:Risk Factors; D014812:Vitamin K / Q000037:antagonists & inhibitors
chemical_list: D000925:Anticoagulants; D002317:Cardiovascular Agents; D004232:Diuretics; D014812:Vitamin K; D004077:Digoxin; D006493:Heparin; D003404:Creatinine